Home  » Topic


Sun Pharma Crashes 6% To A New 52-Week Low
Shares in Sun Pharma slumped a huge 6 per cent after profits at the company crashed by 46 per cent to Rs 1107 crores for the quarter ending Sept 30, 2015. The stock hit a 52-week low of Rs 744 ...
Sun Pharma Crashes 6 A New 52 Week Low

Sun Pharma Shares Up On Patent Litigation Settlement
Shares of the Sun Pharmaceutical Industries was seen trading higher on Tuesday after the company announced that Ranbaxy Pharmaceuticals, a wholly-owned subsidiary entered into a Settlement Agreement with Actavis that dismisses the patent litigation suit relating to Actavis. Check the share ...
Sun Pharma Rallies On BofA-ML Upgrade
Shares in Sun Pharma gained more than 2 percent to Rs 909, after BofA-ML upgraded the stock to "buy" from "neutral", raising its target price to Rs 1,070. Shares in Sun Pharma have seen some buying support in the last ...
Sun Pharma Rallies On Bofa Ml Upgrade
Sun Pharma Shares Fall 14% On Profit, Revenue Warning
Shares in Sun Pharma fell a huge 14 per cent after the company warned of revenues remaining flat and profits being impacted in 2015-16. The stock was last trading at Rs 820, down 14 per cent over Monday's close. Check ...
Ranbaxy in kitty, Sun Pharma to focus on R&D, global reach
Mumbai, Mar 25 (PTI) Sun Pharmaceutical, which today concluded the buyout of Ranbaxy Labs, said the combined entity will expand R&D capabilities and global presence that can lead to a value accretion of USD 250 million over three years. "The ...
Sun Pharma-Ranbaxy USD 4 Billion Merger Completed
Almost a year after announcing a $4 billion deal, Sun Pharmaceutical Industries on Tuesday said merger of Ranbaxy with itself has been 'consummated' following receipt of requisite approvals. In a filing to the Bombay Stock Exchange (BSE), the company said ...
Sun Gets RBI Nod for Transfer of Ranbaxy Overseas Investments
New Delhi, Mar 24 (PTI) Sun Pharmaceutical Industries has received RBI nod for transfer of overseas investments of Ranbaxy to it and issue its shares to the non-resident shareholders of the latter as part of their USD 4-billion merger deal. ...
Sun Gets Rbi Nod Transfer Ranbaxy Overseas Investments
Sun Pharma, Ranbaxy Stocks Rally on Merger Approval
Shares of Sun Pharma and Ranbaxy surged in trade in Monday after the companies received a nod  from the U.S. Federal Trade Commission. The company today announced that the U.S. Federal Trade Commission (FTC) has completed its review of the ...
Pharma in 2014: Deals worth billions and fines worth millions
It's been a year of bitter medicine for Indian pharma companies with fines worth millions of dollars imposed by various foreign regulators, even as they stitched together deals worth billions of dollars, including the high profile Sun-Ranbaxy merger. On the ...
Pharmain 2014 Deals Worth Billions And Fines Worthmillion
Ranbaxy Rallies as CCI Approves Deal with Sun Pharma
Shares in Ranbaxy rallied more than three per cent after CCI approved a deal with Sun Pharma. The stock was up almost 3 per cent at Rs 643. It maybe recalled that earlier this year Sun Pharma said that they ...
Ranbaxy sues US FDA; Stock Slips
Ranbaxy has filed a complaint against the U.S. FDA in federal court and has also asked the Court for a temporary restraining order to prevent any further action by FDA until Ranbaxy's case is decided, the company said in the press ...
Ranbaxy Sues Us Fda Stock Slips
Sun Pharma-Ranbaxy deal gets BSE, NSE clearance
New Delhi: The USD 4-billion merger of Ranbaxy Labs with Sun Pharmaceutical has got clearance from the two leading stock exchanges -- BSE and NSE. The 'no-objection' from the two exchanges would allow the two companies to file their scheme ...
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more